COVID-19 Coagulopathy: Whom to Anticoagulate and How? What Agents to…

Rush University Medical Center

S. Jain

Role of PCSK9 Inhibitors in Diabetes

Stephen Kopecky

Lp(a): When to Measure it and What to Do About it

Canadian Collaborative Research Network

M. O'Donoghue

Updated Lipid Guidelines and Therapy

Complex Coronary Cases

I. Fergus

Recent Cholesterol Guidelines and Integration into Clinical Practice

The North American Thrombosis Forum (NATF)

J. Plutzky, L. Braun, J. Ross

AHA 2022: Cardiovascular Benefit of Lowering LDL Cholesterol Below 4…

AHA 2022 Conference Coverage

N. Marston

Lipids Update: Current Guidelines for Lipid Management

Scripps Health

S. R. Mehta

AHA 2022: Long-Term Efficacy and Safety of Inclisiran in Patients Wi…

AHA 2022 Conference Coverage

K. Ray

Directions of Cardiology in the Next Decade: 2022-2032

Houston Methodist DeBakey Heart and Vascular Center

E. Braunwald

How Do I Reverse Coronary Plaque?

Scripps Health

C. J. Suhar

AHA 2024 Insights: Considerations in Care of Patients with Cancer: P…

AHA 2024 Insights

Y. Bryce

Medical Management of Peripheral Arterial Disease

NY Endovascular Summit

H. Kamran

ACC 2022: Updates on Lowering LDL-C in Secondary Prevention - "Go as…

ACC 2022 Conference Coverage

R. Giugliano

Lipid Lowering Therapies: Where Did We Start, Where We Are Now and W…

The Texas Heart Institute

S. Virani

Peripheral Artery Disease- New Data and New Guidelines. Medical Ther…

Top Ten Topics in Clinical Cardiology 2024

M. Bonaca

Five Things Every Internist Should Know About Anticoagulants

McMaster University Department of Medicine

S. Mithoowani

Rivaroxaban's Role in PAD Management: Where Do We Stand?

UPMC

J. Hornick

I Ordered an Lp(a) Level – Now What?

Canadian Collaborative Research Network

M. O'Donoghue

VICTORION-INITIATE – Comparing Inclisiran First to Usual Care in Pat…

Canadian Collaborative Research Network

M. Gupta

Perioperative Management of Anticoagulants: Podiatry Education Series

Michigan Medicine - Podiatry

M. Munson